Clinical Trial Update: A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nasal administration of foralumab in patients with non-active secondary progressive multiple sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Nasal Foralumab (foralumab)

Snippet

Sponsor: Tiziana Life Sciences LTD | Conditions: Secondary Progressive Multiple Sclerosis | Phase 2 | Status: RECRUITING